a once-daily dry powder inhaler for treatment of COPD in routine clinical practice in a new-user, 1:1 propensity score-matched cohort study. The study included 20,388 propensity score-matched ...
Amarillo Globe-News on MSN8h
What are Zephyr Valves? Groundbreaking COPD treatment brings hope to Panhandle patientsAfter waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...
News Medical on MSN5d
The impact of fall-risk medications on injuries in COPD patientsPeople with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...
Hosted on MSN1mon
Are dry powder inhalers the key to sustainable respiratory care?AstraZeneca’s Symbicort inhaler accounts for most of its inhalation ... While he agrees that DPIs and pMDIs can be equally effective in treating COPD and asthma in clinical studies, pMDIs ...
6don MSN
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...
Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first moderate or severe COPD exacerbation (HR 1.09, 95% CI 1.04-1.14 ...
AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...
Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.
Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...
In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...
Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback